FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Dextroamphetamine Saccharate Recall

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPH…

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class II
Reported by FDA
Jan 20, 2016
Recall ID
D-0566-2016
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Dextroamphetamine Saccharate starting Nov 12, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0566-2016 on Jan 20, 2016. Reason: Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.

Product description

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0972-02, UPC 3 0555-0972-02 0.

Lot numbers, UPCs & expiration codes

Lot #: 34015516A, Exp 05/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0566-2016
Classification
Class II
Status
Terminated
Recall initiated
Nov 12, 2015
FDA report date
Jan 20, 2016
Quantity
9,717 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-0566-2016, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
72988
Address
1090 Horsham Rd
Code information
Lot #: 34015516A, Exp 05/16
Postal code
19454-1505
Report date
Jan 20, 2016
Product type
Drugs
Recall number
D-0566-2016
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
9,717 bottles
Termination date
Nov 1, 2016
Reason for recall
Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0972-02, UPC 3 0555-0972-02 0.
Distribution pattern
Nationwide
Recall initiation date
Nov 12, 2015
Initial firm notification
Letter
Center classification date
Jan 11, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0566-2016, published Jan 20, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls